Engineering Biomedical Materials From total joints to tissue sparing - - PowerPoint PPT Presentation

engineering biomedical materials
SMART_READER_LITE
LIVE PREVIEW

Engineering Biomedical Materials From total joints to tissue sparing - - PowerPoint PPT Presentation

Engineering Biomedical Materials From total joints to tissue sparing Dr. Gavin Braithwaite Cambridge Polymer Group, 56 Roland Street, Suite 310 Boston, MA 02129 CONFIDENTIAL Cambridge Polymer Group, I nc. Testing, Consultation, and


slide-1
SLIDE 1

Cambridge Polymer Group, I nc.

Testing, Consultation, and Instrumentation for Polymeric Materials

Cambridge Polymer Group, 56 Roland Street, Suite 310 Boston, MA 02129 CONFIDENTIAL

7-17 Presentation (10/1/2010)

Engineering Biomedical Materials

From total joints to tissue sparing

  • Dr. Gavin Braithwaite
slide-2
SLIDE 2

Engineering implants

  • Historical device development

– Surgeon determines a need – Engineer provides design to meet primary requirements

  • Often from existing materials

– Incremental improvement iterates towards success

4/19/2011 Cambridge Polymer Group 2 Product improvement Issue determination Gen 1 Gen 2 Gen 3 Gen 4 Product lifecycle

slide-3
SLIDE 3

Biology versus engineering

  • The human body is a finely tuned biomechanical structure

– Meniscus and cartilage

4/19/2011 3 Cambridge Polymer Group

Images: medicinenet.com, MMG, sensorprod.com

slide-4
SLIDE 4

The human hip

  • Ball-and-socket joint
  • Normal gait complex motion

– rotation, flexion, extension

  • Loads can be high

– Walking 3x body weight – Stumbling 9x body weight

  • Critical for mobility and quality of life

Ratner et al.

4/19/2011 4 Cambridge Polymer Group

slide-5
SLIDE 5

What goes wrong

  • Osteoarthritis caused by loss of cartilage

– Bone-on-bone contact – 65% of patients requiring surgery

  • Up to 1M replacements annually
  • Success rate at 10 years post-surgery is between 90-95% typically

– Very good!

4/19/2011 5 Cambridge Polymer Group

Images: hipresurfacing.info, wikipedia

slide-6
SLIDE 6

Hip replacement

  • 1891 First human implant (cemented ivory)
  • 1940 first metal implant
  • Up until the 1960’s, hip fusion (arthrodesis) was the standard

treatment for painful hip joints

– Pain relief, but complete loss of mobility

4/19/2011 6 Cambridge Polymer Group

Images: orthogate

slide-7
SLIDE 7

Engineering a solution

  • Charnley (Manchester)

– Introduced articulating artificial hip joints in the 1960s

  • First attempt – driven by perception of friction

– Low-lubricity

  • PTFE

– Poor wear

– Small head

  • Low contact area

– dislocations

  • Second attempt

– Applied engineering material to surgical problem

  • Polyethylene plastic cog

– Gold standard since 1960’s

Image: Wikipedia

4/19/2011 7 Cambridge Polymer Group

slide-8
SLIDE 8

The next generation

  • Issue: poor wear

– Good toughness, but poor resistance to wear patterns – Erosion of material and osteolysis

  • Solution: crosslinking of the polymer

– HXPE – Lower wear rates

4/19/2011 Cambridge Polymer Group

Ionizing radiation Crosslinks (X) Scissions (X) G(X)~3G(s)

Crystalline lamellae Amorphous regions Irradiate Crosslinks Residual free radicals

8

slide-9
SLIDE 9

Crosslinked UHMWPE

  • 700
  • 600
  • 500
  • 400
  • 300
  • 200
  • 100

100 5 10 15 20 25 30 Cycles (millions) Weight Change (mg)

Highly Crosslinked 22-46 mm

Controls (γ in N2) Control 46mm head (γ in N2) 50 mg/MC

Control 32 mm (γ in air) 31mg/MC

22 mm 15mg/MC 28 mm 17mg/MC

4/19/2011 9 Cambridge Polymer Group

slide-10
SLIDE 10

Material enhancements

  • Issue: Radiation crosslinking generates free-radicals

– Material oxidizes – Premature embrittlement

  • Solution: Crosslinking in inert atmosphere

– Prevent oxidation during processing and storage – Long-term concerns due to in vivo oxidation

Residual free radicals

4/19/2011 10 Cambridge Polymer Group

slide-11
SLIDE 11

State-of-the-art – free radical suppression

  • Issue: Free-radicals persist or an induced in vivo

– Require a method for removing free radicals

  • Solution 1: remove free radicals

– Melt or anneal the material – Does not help in vivo

  • Solution 2: absorb free radicals

– Free radical scavenger – antioxidant – D,L-α-tocopherol (Vitamin E)

  • Crosslink then dope
  • Blend then crosslink

4/19/2011 11 Cambridge Polymer Group

slide-12
SLIDE 12

Vitamin E free radical removal

O CH3 C H3 O H CH3 CH3 CH3 CH3 CH3 CH3

α-tocopherol (Vitamin E, α-T, T-OH)

R + O2 ROO R ROO + T-OH ROOH + TO + Vitamin-E

4/19/2011 12 Cambridge Polymer Group

slide-13
SLIDE 13

Evolution in properties

  • Charnley

– Biocompatible – 10-15 year life when implanted corrected

  • First generation (crosslinked)

– Improved wear – Oxidation issues

  • Second generation (annealed and/or melted)

– Removal of crosslinking free radicals – Sterilization and in vivo radicals remain

  • Third generation (free radical suppression)

– Vitamin E doping – Improved fatigue strength

4/19/2011 13 Cambridge Polymer Group

slide-14
SLIDE 14

Fatigue Crack Propagation

4/19/2011 Cambridge Polymer Group 14

slide-15
SLIDE 15

Next generation

  • Virgin polyethylene

– crack resistant, poor wear, oxidizes

  • Crosslinking

– Improves wear but sacrifices toughness

  • Hybrid structure

– Surface crosslinked - Low VE – Bulk tough - High VE – Antioxidant for protection

4/19/2011 Cambridge Polymer Group 15

0.05 wt% 2 wt% 0.02 wt%

100 kGy

0.00 0.05 0.10 0.15 0.20 0.25 2 4 6 8 10 Depth (mm) Vitamin E Index No homogenization Homogenization for 16 hours

Inhomogeneous doping Spatial crosslinking Homogenize

slide-16
SLIDE 16

Pin-on-disc wear testing

0.2 0.4 0.6 0.8 1 1.2 Highly cross-linked surface Low cross-linked bulk 100-kGy irradiated 100-kGy irradiated and melted Fatigue resistance (MPa m1/2) GRADIENT

4/19/2011 Cambridge Polymer Group

(1) (2) (3) (1) (2) (3)

(1) (2) (3) Wear surfaces 0.5 wt% 0.05 wt% 16

slide-17
SLIDE 17

The success

  • Total hip replacement has evolved

– 1950s simple mechanical replacement – Materials incrementally improved – Highly successful

  • 20+ year implant life
  • >193,000 implants per year in US

– Technology transferred

  • Knee
  • Shoulder
  • Small joints
  • Ankle
  • Spine

Cambridge Polymer Group 17

Image: Ratner et al.

4/19/2011

slide-18
SLIDE 18

Addressing Spine pain

  • In 2004 38 million Americans suffered from back pain

– Muscle – Nerves – Bone – Joint failure

  • Most patients treated conservatively

– anti-inflammatories and physical therapy

  • Degradation of the vertebral column more serious

– Radiculopathy, localized pain and impingement

  • Annual cost for spine conditions $194 billion

– Disc disorders $2.6 billion – Lost activity accounts for 176 million days and 80-90% suffer at some point

  • Treatment of the spine at same point as hip in 1960s

– Gold standard is fusion

4/19/2011 18 Cambridge Polymer Group

Image: http://www.holistix-treatments.co.uk

slide-19
SLIDE 19

The human spine

  • Much more complex than hip joint
  • Supports the upper body

– In activity loads can be 3x body weight and up

  • Protects the spinal chord

– Provides a boney tunnel through which the spinal chord runs

  • Flexible

– Allows rotation/flexion/extension – Hybrid structure of disc and vertebrae

4/19/2011 Cambridge Polymer Group 19

Images: http://www.backpain-guide.com http://www.eorthopod.com

slide-20
SLIDE 20

Spine biomechanics

  • The Intervertebral Disc (IVD) is a unique joint

– Poorly vascularized and immune privileged – Complex structure

  • ply-like periphery (Annulus Fibrosus)
  • surrounds a jelly-like core (Nucleus Pulposus)
  • Hybrid structure

– Annulus confines and contains nucleus – Nucleus transfers compressive loads to tensile loads in annulus – Annulus is not intended for purely compressive loads – Analogous to a bias (cross-ply) tire

4/19/2011 Cambridge Polymer Group 20

Image: Bogduk

slide-21
SLIDE 21

What can go wrong

  • The degenerative cascade

– The IVD starts deteriorating from youth – IVD gradually dehydrates

  • Joint becomes lax
  • Annulus becomes damaged
  • Reduce disc height
  • Facet joints abnormally loaded
  • Pain

– Biomechanics change

  • Bone remodelling
  • Osteophyte formation
  • Arthrosis

– Deterioration also influenced by

  • Lifestyle, trauma, genetics, surgery…

4/19/2011 21 Cambridge Polymer Group

Images: www.spineuniverse.com

slide-22
SLIDE 22

Motion Preservation

4/19/2011 Cambridge Polymer Group 22

Nucleus removal Fusion

  • Removal of nucleus

– Height loss, Ligaments slacken – Abnormal loading

  • 700,000 annually
  • Relieves pressure on spinal chord
  • Removes material – loss of height
  • 50-60% early success, 20-30% later relapse
  • Fusion

– No motion ,Motion/load transferred

  • 300,000 annually
  • Prevents motion
  • 70% clinical success
  • Solution: Total disc replacement

– Analogous to hip replacement – Engineering bearing – Polyethylene on metal

slide-23
SLIDE 23

Bioengineering approach

  • Fusion and total disc relieve symptoms by removal of pain sites

– Changes load distribution in spinal column

  • Nucleus removal relieves symptoms by removing pressure

– Collapses joint

  • Compromised biomechanics

– Accelerates degradation

  • Need method that is

– Less invasive

  • (easier surgery and shorter recovery times)

– Preserves surrounding biomechanics

  • (keep functional structures)

– Restores function

  • (device is biomechanically relevant)

– Revisable

  • (should something go wrong)

Nucleus replacement

4/19/2011 23 Cambridge Polymer Group

slide-24
SLIDE 24

Initial attempts

  • First attempts implanted solid objects into disc space

– Loaded endplates (subsidence) – Large incision

  • Replaced solid objects with expanding devices

– Uneven endplate loading – No load sharing – Moderately large incision

4/19/2011 24 Cambridge Polymer Group

slide-25
SLIDE 25

Ideal treatment

  • Physiology of the intervertebral disc requires pressurization

– Collagen and bone responds to load

  • Proper load-distribution requires fully conforming

– Implies fully fills space

  • Minimal incision to avoid compromising annulus

– Needle delivery

  • Survival of interior of annulus may depend on solute transport

– Free diffusion of solutes

  • Viscoelasticity critical for function

– hydrogel

  • Injectable, space filling, hydrogel

4/19/2011 25 Cambridge Polymer Group

slide-26
SLIDE 26

Performance requirements

  • Injectable

– 30 cm, 3 mm catheter, <70 N force

  • Hydrated

– 80% water

  • Space filling

– Must transfer load evenly to endplates and annulus walls

  • Viscoelastic

– Permeable – Human disc expulses water during day and reabsorbs during night

  • Biocompatible

– No toxic crosslinkers or biproducts – Safe ingredients

  • Resist expulsion

– Annulus compromised by surgical incision, at least

4/19/2011 26 Cambridge Polymer Group

slide-27
SLIDE 27

PVA hydrogels

  • Highly biocompatible
  • Viscoelastic
  • Pharmaceutical grade
  • High molecular weights
  • Freeze-thaw hydrogels

– Crystals force chains together – Thawing allows chain mobility and crystallization – Needs a freezer to manufacture – Phase separation process

4/19/2011 27 Cambridge Polymer Group

Image: Brandrup

slide-28
SLIDE 28

Physics of formation

  • Solvent quality driven phase separation

– Solvent control influences how chains interact

  • Tertiary solvent adjusts solvent quality

– Solution temperature controls how the crosslinks form

  • The balance of the two controls how the solution behaves

4/19/2011 Cambridge Polymer Group 28

Single Polymer Chain in solution Chain Excluded Volume Solution Temperature Tθ Flory Interaction Parameter, 1/χ χ θ(T, P,..)=1/2 Single Polymer Chain in solution Chain Excluded Volume Gaussian distribution Collapsed chain Swollen, distorted chain Polymer Local Density Solvent “Quality” “Bad” “Good” “Theta”

Solvent Rich Polymer Rich

Polymer solution

Animation: math.gmu.edu

slide-29
SLIDE 29

20%-65%* Loading Curve E

0.5 1 1.5 2 2.5 3

DP DP DP AG RSA3 AG RSA3 AG RSA3- PEG AG RSA3- PEG 1FT 5FT 5FT 10-28 15-28 25-28 15-28 25-28 15-28 25-28 15-28 15-28 15%

Elastic Modulus [MPa]

Morphology of “thetagels”

4/19/2011 Cambridge Polymer Group 29

n=5

Image box approximately 60 microns

slide-30
SLIDE 30

Testing

  • Standard tests

– Rheology – Modulus – Morphology

  • Non-standard tests

– Fatigue – In situ gelling

  • Testing that is relevant to the material and environment

– No longer a conventional rigid material (steel/polyethylene) – Allow ingress/egress of fluid – Contain implant – Reflect surgical constraints

4/19/2011 30 Cambridge Polymer Group

slide-31
SLIDE 31

Rheology – 15% PVA in water

4/19/2011 31 Cambridge Polymer Group

slide-32
SLIDE 32

Rheology – 15% PVA with gellant

4/19/2011 32 Cambridge Polymer Group

slide-33
SLIDE 33

Gelation

  • In a solvent quality driven system, concentration is critical
  • The hydrated environment in vivo must impact an injectable

hydrogel formulation through

– Diffusion out of active ingredients (polymer, gellant, crosslinker) – Diffusion in of water and bodily fluids (dilution)

Fail Little opacity Diffuse interface Pass Completely opaque Sharp interface

33 4/19/2011 Cambridge Polymer Group

slide-34
SLIDE 34

Fatigue

  • Cyclic fatigue of hydrogel

– Confining annulus model (reflects confinement in vivo) – Porous end plates (reflects partially permeable endplates) – Relevant deformation – 40 ºC, 2750N ± 250N, 1Hz

5 mm hole Nucleus cavity RTV Annulus Porous end-plates Membrane

4/19/2011 34 Cambridge Polymer Group

slide-35
SLIDE 35

Fatigue

  • RTV annulus acts purely elastically
  • Hydrogel filled annulus

– Water loss initially – Equilibrium pressurized condition

4/19/2011 Cambridge Polymer Group 35

slide-36
SLIDE 36

Formulation development

  • PVA solution behavior controlled by temperature, solvent and

molecular weight

– Low temperature allows crosslinks to form – Poor solvent allows polymer to phase separate

  • Solvent quality also influenced by temperature

– Higher molecular weight PVA retards chain kinetics – Higher molecular weight PEG fills less volume

  • Complex parameter space

– Gelation time – Injection viscosity – Final morphology

  • Mechanical properties and permeability

– Resistance to environment – Fatigue strength/fracture resistance

  • Design of Experiment

4/19/2011 36 Cambridge Polymer Group

slide-37
SLIDE 37

Design of Experiment

  • Statistical design of experimental plan to examine relationships

between explanatory and response variables

  • Systematic way of sampling the parameter space
  • Prediction optimal formulations
  • Limited assumptions

– removes “intuitive” experimentation

4/19/2011 37 Cambridge Polymer Group

slide-38
SLIDE 38

Conclusions

  • Biomedical implants started as engineering solutions to the primary

problem

– In some cases work extremely well

  • Hip is an excellent example
  • Gradually iterated towards one of the most successful current devices

– Weakness is that they often don’t consider impact on secondary

  • Spine demonstrates the issues with a simple-minded engineering approach
  • Removal of functional tissue and transfer of loads to rest of system
  • New breed of materials are designed to mimic physiology

– Addresses direct cause of problem

  • Prolapsed disc due to degraded nucleus

– Sympathetic to surrounding physiology

  • Preserves biomechanics and nutrition

– Very complex to test and validate

4/19/2011 38 Cambridge Polymer Group

slide-39
SLIDE 39

Biomaterials

  • Earliest implants were generally external

– Dental

  • 600 AD nacre teeth

– Wound closure

  • Egyptian linen sutures

– Visual

  • 1860 glass contact lenses
  • Implanted materials

– Late 19th century

  • Metals for bone fixation

– Early 1940s

  • Plastics
  • “Engineering” materials

4/19/2011 39 Cambridge Polymer Group

slide-40
SLIDE 40

Free radicals cause oxidation

4/19/2011 Cambridge Polymer Group

0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 Conventional 100kGy 100 kGy melted Fatigue crack propagation resistance

Unaged Aged

40

slide-41
SLIDE 41
  • Cyclic loading stresses chains

– Induces oxidation

Environmental Stress Cracking (ESC)

4/19/2011 Cambridge Polymer Group 41

0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1 2 3 4 5 6 Depth (mm) Oxidation Index (A.U.)

100kGy VitE/PE ESC Cycled 1 100kGy VitE/PE ESC Cycled 2 100kGy VitE/PE ESC Cycled 3 100kGy VitE/PE ESC Cycled 4 100kGy VitE/PE Uncycled

Vitamin-E Polyethylene 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1 2 3 4 5 6 Depth (mm) Oxidation Index (A.U.)

  • Seq. Irradiate/Anneal -

Cycled

  • Seq. Irradiate/Anneal -

Uncycled Sequential Irradiation and Annealing

slide-42
SLIDE 42

Total disc replacement

  • Relieves pain

– Like fusion, removes source of pain

  • Restores motion and height

– Allows the joint to move

  • Weaknesses

– Highly invasive

  • Anterior surgery

– Changes adjacent segment biomechanics

  • Resects ALL, removes significant stabilizing

structures

  • Mobile bearing does not mimic tensile properties of

system

  • Fusion or joint replacement too aggressive for

mild degeneration

4/19/2011 42 Cambridge Polymer Group

Image: spineuniverse.com

slide-43
SLIDE 43

Competitive solutions

  • Spine Wave

– Silk-like protein based crosslinked hydrogel – Pivotal US clinical trials

  • Disc Dynamics

– Curing PCU elastomer in balloon – Cancelled US clinical trials

  • Cryolife

– Crosslinked bovine serum albumin hydrogel

  • Gentis

– Crosslinked Lauryl acrylate

  • Sythes-Stratec

– Phase-change polyNIPAAm

  • TranS1

– Curing silicone elastomer

4/19/2011 Cambridge Polymer Group 43

slide-44
SLIDE 44

Solvent quality

  • A function of temperature, or of chemical species

– Critical point is the “theta” point of the solution

  • Any osmotically active tertiary ingredient can be used, sensitive to

chemistry and molecular weight

– PEG 200 ~25% – PEG 400 ~18% – PEG 600 ~15% – NaCl ~12% – Glycine ~12% – PEG 1000 ~10% – Chondroitin Sulfate ~ 2%

Solvent Concentration Theta Temp [°C] t-Butanol/water 32% 25 Ethanol/Water 41.5% 25 NaCl/Water 2 mol/L 25 Water

  • 25

4/19/2011 44 Cambridge Polymer Group

Table: Polymer handbook

slide-45
SLIDE 45

4/19/2011 45 Cambridge Polymer Group

slide-46
SLIDE 46

Demographics and solutions

4/19/2011 Cambridge Polymer Group 46

Image: healthlibrary.epnet.com

http://www.eorthopod.com

  • Treatment options

– Most patients can be treated conservatively – Discectomy

  • 700,000 annually
  • Relieves pressure on spinal chord
  • Removes material – loss of height
  • 50-60% early success, 20-30% later relapse

– Fusion

  • 300,000 annually
  • Prevents motion
  • 70% clinical success but transfers loads to adjacent joints